uniQure
QURE
#3987
Rank
A$4.73 B
Marketcap
A$68.84
Share price
-3.24%
Change (1 day)
224.47%
Change (1 year)

uniQure (QURE) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$0.91 Billion

According to uniQure's latest financial reports the company's total liabilities are A$0.91 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

uniQure - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.93 B3.2%
2024-12-31A$0.90 B-1.13%
2023-12-31A$0.91 B172.23%
2022-12-31A$0.33 B14.3%
2021-12-31A$0.29 B134.57%
2020-12-31A$0.12 B-30.03%
2019-12-31A$0.17 B33.99%
2018-12-31A$0.13 B-13.12%
2017-12-31A$0.15 B-12.3%
2016-12-31A$0.17 B-5.01%
2015-12-31A$0.18 B136.19%
2014-12-31A$78.3 M51.42%
2013-12-31A$51.71 M575.58%
2012-12-31A$7.65 M-27.88%
2011-12-31A$10.61 M-10.36%
2010-12-31A$11.84 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
A$120.72 B 13,137.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$92.04 B 9,992.81%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
A$0.11 B-86.91%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
A$0.51 B-43.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$3.44 B 277.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A$0.39 B-57.19%๐Ÿ‡บ๐Ÿ‡ธ USA